PMID- 37575534 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20230815 IS - 2514-2119 (Electronic) IS - 2514-2119 (Linking) VI - 7 IP - 8 DP - 2023 Aug TI - Haemodynamic effects of inhaled nitric oxide in acute myocardial infarction complicated by right heart failure under ECPELLA support: case report. PG - ytad369 LID - 10.1093/ehjcr/ytad369 [doi] LID - ytad369 AB - BACKGROUND: Recently, mechanical support obtained with the combination of venoarterial extracorporeal membrane oxygenation (VA-ECMO) and an Impella device, together referred to as ECPELLA, has been shown to be effective for acute myocardial infarction with cardiogenic shock. However, methods for withdrawing VA-ECMO in acute myocardial infarction cases complicated by right ventricular dysfunction are yet to be established. Here, we report the effective use of inhaled nitric oxide during the weaning of VA-ECMO from the ECPELLA management of a patient with acute myocardial infarction with cardiogenic shock. CASE SUMMARY: An 81-year-old man with an acute extensive anterior wall myocardial infarction with cardiogenic shock was supported with ECPELLA to improve his haemodynamics. During ECPELLA, the Impella device could not maintain sufficient flow. Echocardiography revealed a small left ventricle and an enlarged right ventricle, indicating acute right heart failure. Inhaled nitric oxide was initiated to reduce right ventricle afterload, which decreased pulmonary artery pressure from 34/20 to 27/13 mmHg, improved right and left ventricle sizes, and stabilized the Impella support. Afterward, VA-ECMO could be withdrawn because the Impella alone was sufficient for haemodynamic support. DISCUSSION: Inhaled nitric oxide improved right ventricle performance in a patient with severe myocardial infarction with right heart failure supported by ECPELLA. Thus, we suggest that inhaled nitric oxide facilitates the weaning of VA-ECMO from patients with refractory right ventricular dysfunction who are supported by ECPELLA. CI - (c) The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. FAU - Fujita, Kosuke AU - Fujita K AUID- ORCID: 0000-0003-2001-1543 AD - Department of Cardiology, Kindai University Hospital, 377-2 Onohigashi Osakasayamashi, 589-8511 Osaka, Japan. FAU - Ueno, Masafumi AU - Ueno M AD - Department of Cardiology, Kindai University Hospital, 377-2 Onohigashi Osakasayamashi, 589-8511 Osaka, Japan. FAU - Yasuda, Masakazu AU - Yasuda M AD - Department of Cardiology, Kindai University Hospital, 377-2 Onohigashi Osakasayamashi, 589-8511 Osaka, Japan. FAU - Mizutani, Kazuki AU - Mizutani K AD - Department of Cardiology, Kindai University Hospital, 377-2 Onohigashi Osakasayamashi, 589-8511 Osaka, Japan. FAU - Miyoshi, Tatsuya AU - Miyoshi T AD - Department of Cardiology, Kindai University Hospital, 377-2 Onohigashi Osakasayamashi, 589-8511 Osaka, Japan. FAU - Nakazawa, Gaku AU - Nakazawa G AUID- ORCID: 0000-0002-6721-1342 AD - Department of Cardiology, Kindai University Hospital, 377-2 Onohigashi Osakasayamashi, 589-8511 Osaka, Japan. LA - eng PT - Case Reports DEP - 20230802 PL - England TA - Eur Heart J Case Rep JT - European heart journal. Case reports JID - 101730741 PMC - PMC10422691 OTO - NOTNLM OT - Acute myocardial infarction OT - Case report OT - ECPELLA OT - Impella OT - Inhaled nitric oxide OT - VA-ECMO COIS- Conflict of interest: None declared. EDAT- 2023/08/14 06:43 MHDA- 2023/08/14 06:44 PMCR- 2023/08/02 CRDT- 2023/08/14 04:31 PHST- 2022/12/07 00:00 [received] PHST- 2023/07/12 00:00 [revised] PHST- 2023/07/31 00:00 [accepted] PHST- 2023/08/14 06:44 [medline] PHST- 2023/08/14 06:43 [pubmed] PHST- 2023/08/14 04:31 [entrez] PHST- 2023/08/02 00:00 [pmc-release] AID - ytad369 [pii] AID - 10.1093/ehjcr/ytad369 [doi] PST - epublish SO - Eur Heart J Case Rep. 2023 Aug 2;7(8):ytad369. doi: 10.1093/ehjcr/ytad369. eCollection 2023 Aug.